Sana Biotechnology (SANA), a clinical-stage ... modified islet cells were able to evade immune system attacks. CEO Steve Harr stated, “As far as we are aware, this is the first study showing ...

As researchers push for a type 1 diabetes cure, Sana Biotechnology has provided a nudge forward with new, if limited, ...

Shares of Sana Biotechnology surged after the company ... intramuscularly with no immunosuppression," Chief Executive Steve Harr said.

SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology ... will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer. The webcast will ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

and evasion of immune detection of HIP-modified primary pancreatic islet cells transplanted intramuscularly with no immunosuppression,” said Steve Harr, Sana’s President and Chief Executive Officer.